103 results on '"MORBELLI, Silvia"'
Search Results
2. Mandatory role of endoplasmic reticulum and its pentose phosphate shunt in the myocardial defense mechanisms against the redox stress induced by anthracyclines
3. Mycoplasma hominis as Cause of Extragenital Infection in Patients with Hypogammaglobulinemia: Report of 2 Cases and Literature Review
4. Neuroimaging biomarkers in the biological definition of Parkinson’s disease and dementia with Lewy bodies – EANM position on current state, unmet needs and future perspectives
5. The Homunculus of unspecific bone uptakes associated with PSMA-targeted tracers: a systematic review-based definition
6. Automatic quantification of REM sleep without atonia reliably identifies patients with REM sleep behavior disorder: a possible screening tool?
7. Progression trajectories from prodromal to overt synucleinopathies: a longitudinal, multicentric brain [18F]FDG-PET study
8. Egesta Lopci, Luigi Mansi (editors). Advanced imaging and therapy in neuro-oncology, 1st edition. Springer, 2024. ISBN: 978-3-031-59340-6
9. Highlights of the 36th EANM Annual Congress 2023, from hometown Vienna, Austria: “A SYMPHONY OF SCIENCE”
10. EANM practice guidelines for an appropriate use of PET and SPECT for patients with epilepsy
11. Diagnostic performance of molecular imaging methods in predicting the progression from mild cognitive impairment to dementia: an updated systematic review
12. Diagnostic and prognostic value of dual-point amyloid PET in Alzheimer’s disease (AD) mimickers
13. Alzheimer’s disease (AD) co-pathology in dementia with Lewy bodies (DLB): implications in the disease modification era
14. Autoimmune encephalitis: what the radiologist needs to know
15. Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease
16. Perspectives of the European Association of Nuclear Medicine on the role of artificial intelligence (AI) in molecular brain imaging
17. Metabolic network alterations as a supportive biomarker in dementia with Lewy bodies with preserved dopamine transmission
18. EANM position paper: theranostics in brain tumours—the present and the future
19. Validation of the REM behaviour disorder phenoconversion-related pattern in an independent cohort
20. Correction to: Highlights of the 36th EANM Annual Congress 2023, from hometown Vienna, Austria: “A SYMPHONY OF SCIENCE”
21. Apporto iodico e potenziali interferenze con le pratiche diagnostico-terapeutiche in ambito medico-nucleare
22. Superfluous, controversial and luxury issues in nuclear medicine
23. The diagnostic and prognostic role of combined [18F]FDG and [68Ga]-DOTA-peptides PET/CT in primary pulmonary carcinoids: a multicentric experience
24. Gene’s expression underpinning the divergent predictive value of [18F]F-fluorodeoxyglucose and prostate-specific membrane antigen positron emission tomography in primary prostate cancer: a bioinformatic and experimental study
25. Combined forced diuresis and late acquisition on [68Ga]Ga-PSMA-11 PET/CT for biochemical recurrent prostate cancer: a clinical practice-oriented study
26. Different z-score cut-offs for striatal binding ratio (SBR) of DaT SPECT are needed to support the diagnosis of Parkinson’s Disease (PD) and dementia with Lewy bodies (DLB)
27. Adopting transfer learning for neuroimaging: a comparative analysis with a custom 3D convolution neural network model
28. Time-dependent recovery of brain hypometabolism in neuro-COVID-19 patients
29. FDA approval of lecanemab: the real start of widespread amyloid PET use? — the EANM Neuroimaging Committee perspective
30. Intravenous immunoglobulin bridging to rituximab in NMDAR encephalitis patients non-responders to first-line treatments
31. A comparison of advanced semi-quantitative amyloid PET analysis methods
32. 2-[18F]-FDG PET for imaging brain involvement in patients with long COVID: perspective of the EANM Neuroimaging Committee
33. Prognostic value of immunotherapy-induced organ inflammation assessed on 18FDG PET in patients with metastatic non-small cell lung cancer
34. Longitudinal analysis of atherosclerotic plaques evolution: an 18F-NaF PET/CT study
35. Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson’s disease (PD) do not overlap
36. Opportunistic skeletal muscle metrics as prognostic tools in metastatic castration-resistant prostate cancer patients candidates to receive Radium-223
37. Polysomnographic correlates of sleep disturbances in de novo, drug naïve Parkinson’s Disease
38. Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer’s disease
39. EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3
40. A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer’s disease, and mild cognitive impairment using brain 18F-FDG PET
41. The prognostic power of 18F-FDG PET/CT extends to estimating systemic treatment response duration in metastatic castration-resistant prostate cancer (mCRPC) patients
42. SARS-CoV-2-related encephalitis with prominent parkinsonism: clinical and FDG-PET correlates in two patients
43. Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study
44. Cuneus/precuneus as a central hub for brain functional connectivity of mild cognitive impairment in idiopathic REM sleep behavior patients
45. Amyloid PET in the diagnostic workup of neurodegenerative disease
46. 18F-fluoro-2-deoxy-d-glucose (FDG) uptake. What are we looking at?
47. Increased myocardial 18F-FDG uptake as a marker of Doxorubicin-induced oxidative stress
48. EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0
49. Correction to: EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3
50. Increased 68 Ga-PSMA-11 Bone Marrow and Splenic Uptake in a Case of Erythroid Myelodysplasia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.